257 related articles for article (PubMed ID: 29215653)
1. Prevalence of neurofibromatosis type 1 in the Finnish population.
Kallionpää RA; Uusitalo E; Leppävirta J; Pöyhönen M; Peltonen S; Peltonen J
Genet Med; 2018 Sep; 20(9):1082-1086. PubMed ID: 29215653
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract][Full Text] [Related]
4. Increased risk for dementia in neurofibromatosis type 1.
Kallionpää RA; Valtanen M; Auranen K; Uusitalo E; Rinne JO; Peltonen S; Peltonen J
Genet Med; 2021 Nov; 23(11):2219-2222. PubMed ID: 34257422
[TBL] [Abstract][Full Text] [Related]
5. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
6. A clinical assessment of neurofibromatosis type 1 (NF1) and segmental NF in Northern Finland.
Poyhonen M
J Med Genet; 2000 Dec; 37(12):E43. PubMed ID: 11106361
[No Abstract] [Full Text] [Related]
7. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 1 of the child increases birth weight.
Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Peltonen J; Peltonen S
Am J Med Genet A; 2019 Jul; 179(7):1173-1183. PubMed ID: 31016862
[TBL] [Abstract][Full Text] [Related]
9. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.
Friedman JM; Birch PH
Am J Med Genet; 1997 May; 70(2):138-43. PubMed ID: 9128932
[TBL] [Abstract][Full Text] [Related]
10. The pregnancy in neurofibromatosis 1: A retrospective register-based total population study.
Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Timonen S; Peltonen J; Peltonen S
Am J Med Genet A; 2017 Oct; 173(10):2641-2648. PubMed ID: 28815922
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage.
Kurtelius A; Kallionpää RA; Huttunen J; Huttunen TJ; Helin K; Koivisto T; Frösen J; von Und Zu Fraunberg M; Peltonen S; Peltonen J; Jääskeläinen JE; Lindgren AE
PLoS One; 2017; 12(6):e0178711. PubMed ID: 28575128
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia.
Van Royen K; Brems H; Legius E; Lammens J; Laumen A
Eur J Pediatr; 2016 Sep; 175(9):1193-1198. PubMed ID: 27519821
[TBL] [Abstract][Full Text] [Related]
13. A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age.
Heervä E; Koffert A; Jokinen E; Kuorilehto T; Peltonen S; Aro HT; Peltonen J
J Bone Miner Res; 2012 Nov; 27(11):2333-7. PubMed ID: 22692994
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment.
Lammert M; Friedman JM; Kluwe L; Mautner VF
Arch Dermatol; 2005 Jan; 141(1):71-4. PubMed ID: 15655144
[TBL] [Abstract][Full Text] [Related]
15. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis.
Lee TJ; Chopra M; Kim RH; Parkin PC; Barnett-Tapia C
Orphanet J Rare Dis; 2023 Sep; 18(1):292. PubMed ID: 37710322
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 1 and childhood cancer.
Matsui I; Tanimura M; Kobayashi N; Sawada T; Nagahara N; Akatsuka J
Cancer; 1993 Nov; 72(9):2746-54. PubMed ID: 8402499
[TBL] [Abstract][Full Text] [Related]
19. The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1.
Chilibeck CM; Shah S; Russell HC; Vincent AL
Ophthalmic Genet; 2021 Jun; 42(3):223-229. PubMed ID: 33594930
[No Abstract] [Full Text] [Related]
20. Evaluation of neurofibromatosis type 1 progression using a nationwide registry of patients who submitted claims for medical expense subsidies in Japan between 2008 and 2012.
Yamauchi T; Suka M; Nishigori C; Yanagisawa H
Orphanet J Rare Dis; 2019 Jul; 14(1):166. PubMed ID: 31277677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
